Synthesis and antimalarial activity of new Fluoroamodiaquine analogues

Vol. 1, 2019. - 117971
Pôster
Favorite this paper
How to cite this paper?
Abstract

Based on new cases of resistance of Plasmodium falciparum to antimalarial drugs, the need for research of new antimalarial drug candidates is urgent1. Molecular docking studies on a series of fluoroamodiaquine (FAQ) analogues were previously conducted by our research group and a synthetic route was planned2. Here, we propose the synthesis of new FAQ analogues using the previously described methodology (Figure 1).
The compounds were tested in vitro against a sensitive and resistant chloroquine strains of Plasmodium falciparum (NF54 and K1, respectively)3. Compounds 7a and 7b presented the lowest IC50 values, highlighting their results against the resistant strain K1, which were lowest than chloroquine (0,015 and 0,057μM). These compounds also demonstrated the best cytotoxicity profile. The β-hematin assay was also performed presenting inhibition profile similar to amodiaquine and chloroquine. The molecular docking is in progress. These results indicate that FAQ analogues are promising molecules for the treatment of malaria.

Institutions
  • 1 Universidade Federal do Rio de Janeiro
  • 2 Department of Chemistry / Bioinorganic Research Group / University of Cape Town
Track
  • Medicinal Chemistry
Keywords
Antiplasmodial Activity
amodiaquine analogues
piperazine